Ovid Therapeutics Inc. Common Stock
Symbol: OVID (NASDAQ)
1.28
▲ (2.00%) 0.025
Company Description:
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
Key Stats
- Today's Open: $1.297
- Today's High: $1.34
- Today's Low: $1.27
- Today's Volume: 13.28K
- Yesterday Close: $1.25
- Yesterday High: $1.35
- Yesterday Low: $1.2
- Yesterday Volume: 1.73M
- Last Min Volume: 38
- Last Min High: $1.282
- Last Min Low: $1.27
- Last Min VWAP: $1.27
Company Profile
- Name: Ovid Therapeutics Inc. Common Stock
- Website: https://www.ovidrx.com
- Listed Date: 2017-05-05
- Location: NEW YORK, NY
- Market Status: Active
- CIK Number: 0001636651
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $88.89M
- Round Lot: 100
- Outstanding Shares: 71.11M
- Asset Type: CS
RECENT FILINGS FOR OVID
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-13 | 10-Q | View |
| 2025-08-13 | 8-K | View |
| 2025-07-21 | SCHEDULE 13G/A | View |
| 2025-07-17 | SCHEDULE 13G/A | View |
| 2025-07-10 | 8-K | View |
| 2025-07-09 | SCHEDULE 13G/A | View |
| 2025-06-25 | 8-K | View |
| 2025-06-18 | 4 | View |
| 2025-06-18 | 4 | View |
| 2025-06-18 | 4 | View |
| 2025-06-18 | 4 | View |
| 2025-05-22 | ARS | View |
| 2025-05-22 | DEFA14A | View |
| 2025-05-22 | DEF 14A | View |
| 2025-05-13 | 10-Q | View |
| 2025-05-13 | 8-K | View |
| 2025-05-02 | 8-K | View |
| 2025-05-02 | PRE 14A | View |
| 2025-04-30 | 10-K/A | View |
| 2025-03-11 | 10-K | View |
Latest News on OVID